Senate approves extension of FISA surveillance just after deadline
Related Articles
-
FDA approves bladder cancer treatment by Culver City company
The Food and Drug Administration on Monday approved a new treatment for a type of bladder cancer. The treatment, which will be sold under the brand name Anktiva, is intended for some patients suffering from certain types of non-muscle invasive bladder cancer, according to an FDA statement announcing the approval. News of the FDA action was first reported by Reuters, which said, "The therapy works by activating types of disease fighting white blood cells called natural killer (NK) cells and...
-
Michigan approves 'extremely toxic' copper mine just 100ft from Lake Superior
A copper mine will become the closest site to open near Lake Superior. Environmentalists fear the mine will dispose mining waste into the lake and park. The mining company paid a $25,000 fine in 2018 for damaging local wetlands. READ MORE:
-
Stanford doctors help develop first FDA-approved gene-editing treatment
The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug development and FDA approval, is the first gene-editing medical treatment to recieve FDA approval.